OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal on Q2 2020 Results - Earnings Call Transcript
Opiant Pharmaceuticals, Inc. (OPNT)
Q2 2020 Earnings Conference Call
August 06, 2020, 16:30 ET
Company Participants
Ben Atkins - VP, Communications & IR
Roger Crystal - President, CEO & Director
David O'Toole - CFO
Conference Call Participants
Brandon Folkes - Cantor Fitzgerald & Co.
David Bautz - Zacks Investment Research
Presentation
Operator
Greetings and welcome to the Opiant Pharmaceuticals' Second Quarter 2020 Earnings Conference Call. [Operator Instructions]. It is now my pleasure to introduce your host, Ben Atkins, Vice President of Communications and Investor Relations for Opiant Pharmaceuticals. Thank you, Mr. Atkins. You may begin.